Merck's HIV treatment meets main goal of two late-stage studies
Dec 19, 2024 4:22 AM
(Reuters) - Merck ( MRK ) said on Thursday its experimental drug combination to treat some adults with HIV-1 infection met the main goal of two late-stage studies.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.